View Future GrowthOBM Drilchem 과거 순이익 실적과거 기준 점검 2/6OBM Drilchem은 연평균 28%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 12.9% 증가했습니다. 매출은 연평균 19.6%의 비율로 증가했습니다. OBM Drilchem의 자기자본이익률은 16.3%이고 순이익률은 19.7%입니다.핵심 정보28.01%순이익 성장률22.01%주당순이익(EPS) 성장률Chemicals 산업 성장률8.96%매출 성장률19.61%자기자본이익률16.26%순이익률19.72%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Jun 04First quarter 2024 earnings released: EPS: Rp23.63 (vs Rp11.75 in 1Q 2023)First quarter 2024 results: EPS: Rp23.63 (up from Rp11.75 in 1Q 2023). Revenue: Rp53.4b (up 46% from 1Q 2023). Net income: Rp19.0b (up 101% from 1Q 2023). Profit margin: 36% (up from 26% in 1Q 2023). The increase in margin was driven by higher revenue.Reported Earnings • Apr 02Full year 2023 earnings released: EPS: Rp30.26 (vs Rp12.15 in FY 2022)Full year 2023 results: EPS: Rp30.26 (up from Rp12.15 in FY 2022). Revenue: Rp154.5b (up 50% from FY 2022). Net income: Rp24.4b (up 205% from FY 2022). Profit margin: 16% (up from 7.7% in FY 2022). The increase in margin was driven by higher revenue.Reported Earnings • Dec 03Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: Rp21.13. Net income: Rp17.0b (up Rp17.0b from 3Q 2022).Reported Earnings • Sep 03Second quarter 2023 earnings releasedSecond quarter 2023 results: EPS: Rp12.47. Net income: Rp11.9b (up Rp11.9b from 2Q 2022).Reported Earnings • May 08Full year 2022 earnings released: EPS: Rp12.15 (vs Rp8.27 in FY 2021)Full year 2022 results: EPS: Rp12.15 (up from Rp8.27 in FY 2021). Revenue: Rp103.3b (up 55% from FY 2021). Net income: Rp7.99b (up 76% from FY 2021). Profit margin: 7.7% (up from 6.8% in FY 2021). The increase in margin was driven by higher revenue.모든 업데이트 보기Recent updatesNew Risk • May 18New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Rp172.5b (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.공시 • May 04PT OBM Drilchem Tbk, Annual General Meeting, Jun 10, 2026PT OBM Drilchem Tbk, Annual General Meeting, Jun 10, 2026. Location: jakarta IndonesiaNew Risk • Mar 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (Rp188.6b market cap, or US$11.1m).Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improves as stock rises 25%After last week's 25% share price gain to Rp340, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 18x in the Chemicals industry in Indonesia. Total returns to shareholders of 105% over the past three years.Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to Rp296, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 50% over the past three years.Board Change • Oct 14No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. No independent directors (4 non-independent directors). Commissioner Andang Bachtiar was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Jun 19PT OBM Drilchem Tbk, Annual General Meeting, Jun 19, 2025PT OBM Drilchem Tbk, Annual General Meeting, Jun 19, 2025. Location: conference room suite 7e 7th fl dipo business, center jl gatot subroto kav 50-52 rt 001 rw 007, kel tanah abang jakarta pusat dk jakarta kota adm, jakarta pusat dki, IndonesiaValuation Update With 7 Day Price Move • Nov 07Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to Rp187, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 12x in the Chemicals industry in Indonesia. Total loss to shareholders of 27% over the past year.Recent Insider Transactions • Aug 29President Director recently sold Rp1.2b worth of stockOn the 23rd of August, Ryanto Husodo sold around 5m shares on-market at roughly Rp255 per share. This transaction amounted to 6.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Ryanto's only on-market trade for the last 12 months.New Risk • Jun 16New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (Rp212.8b market cap, or US$13.0m).Reported Earnings • Jun 04First quarter 2024 earnings released: EPS: Rp23.63 (vs Rp11.75 in 1Q 2023)First quarter 2024 results: EPS: Rp23.63 (up from Rp11.75 in 1Q 2023). Revenue: Rp53.4b (up 46% from 1Q 2023). Net income: Rp19.0b (up 101% from 1Q 2023). Profit margin: 36% (up from 26% in 1Q 2023). The increase in margin was driven by higher revenue.공시 • May 09PT OBM Drilchem Tbk, Annual General Meeting, Jun 13, 2024PT OBM Drilchem Tbk, Annual General Meeting, Jun 13, 2024.Reported Earnings • Apr 02Full year 2023 earnings released: EPS: Rp30.26 (vs Rp12.15 in FY 2022)Full year 2023 results: EPS: Rp30.26 (up from Rp12.15 in FY 2022). Revenue: Rp154.5b (up 50% from FY 2022). Net income: Rp24.4b (up 205% from FY 2022). Profit margin: 16% (up from 7.7% in FY 2022). The increase in margin was driven by higher revenue.Reported Earnings • Dec 03Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: Rp21.13. Net income: Rp17.0b (up Rp17.0b from 3Q 2022).Reported Earnings • Sep 03Second quarter 2023 earnings releasedSecond quarter 2023 results: EPS: Rp12.47. Net income: Rp11.9b (up Rp11.9b from 2Q 2022).Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 22%After last week's 22% share price gain to Rp276, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 18x in the Chemicals industry in Indonesia. Total returns to shareholders of 96% over the past year.New Risk • Jul 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (Rp178.9b market cap, or US$11.8m).Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improves as stock rises 23%After last week's 23% share price gain to Rp222, the stock trades at a trailing P/E ratio of 22.4x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 56% over the past year.New Risk • Jun 12New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (Rp145.1b market cap, or US$9.75m). Minor Risk Shareholders have been diluted in the past year (10% increase in shares outstanding).Reported Earnings • May 08Full year 2022 earnings released: EPS: Rp12.15 (vs Rp8.27 in FY 2021)Full year 2022 results: EPS: Rp12.15 (up from Rp8.27 in FY 2021). Revenue: Rp103.3b (up 55% from FY 2021). Net income: Rp7.99b (up 76% from FY 2021). Profit margin: 7.7% (up from 6.8% in FY 2021). The increase in margin was driven by higher revenue.Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 24%After last week's 24% share price gain to Rp188, the stock trades at a trailing P/E ratio of 30.2x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 100% over the past year.Valuation Update With 7 Day Price Move • Feb 27Investor sentiment improves as stock rises 26%After last week's 26% share price gain to Rp216, the stock trades at a trailing P/E ratio of 34.8x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 88% over the past year.Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Tumbur Nainggolan was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Tumbur Nainggolan was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역OBM Drilchem가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이IDX:OBMD 매출, 비용 및 순이익 (IDR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25171,90033,899110,090030 Sep 25163,63126,477108,635030 Jun 25159,94332,93996,504031 Mar 25158,28528,296101,974031 Dec 24169,64238,63693,707030 Sep 24163,49423,10792,645030 Jun 24165,08127,40992,264031 Mar 24171,29333,96382,819031 Dec 23154,48924,38682,374030 Sep 23149,04831,40282,370030 Jun 23130,75918,78982,002031 Mar 23112,37910,84279,244031 Dec 22103,3247,98975,957030 Sep 2297,40319,53462,545030 Jun 2292,01416,99159,493031 Mar 2279,44910,77055,011031 Dec 2166,8834,54950,528031 Dec 2059,9887,28743,5030양질의 수익: OBMD는 고품질 수익을 보유하고 있습니다.이익 마진 증가: OBMD의 현재 순 이익률 (19.7%)은 지난해 (22.8%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: OBMD의 수익은 지난 5년 동안 연평균 28%로 크게 증가했습니다.성장 가속화: OBMD은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: OBMD은 지난 1년 동안 수익이 감소(-12.3%)하여 Chemicals 업계 평균(12%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: OBMD의 자본 수익률(16.3%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 08:38종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스PT OBM Drilchem Tbk는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Jun 04First quarter 2024 earnings released: EPS: Rp23.63 (vs Rp11.75 in 1Q 2023)First quarter 2024 results: EPS: Rp23.63 (up from Rp11.75 in 1Q 2023). Revenue: Rp53.4b (up 46% from 1Q 2023). Net income: Rp19.0b (up 101% from 1Q 2023). Profit margin: 36% (up from 26% in 1Q 2023). The increase in margin was driven by higher revenue.
Reported Earnings • Apr 02Full year 2023 earnings released: EPS: Rp30.26 (vs Rp12.15 in FY 2022)Full year 2023 results: EPS: Rp30.26 (up from Rp12.15 in FY 2022). Revenue: Rp154.5b (up 50% from FY 2022). Net income: Rp24.4b (up 205% from FY 2022). Profit margin: 16% (up from 7.7% in FY 2022). The increase in margin was driven by higher revenue.
Reported Earnings • Dec 03Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: Rp21.13. Net income: Rp17.0b (up Rp17.0b from 3Q 2022).
Reported Earnings • Sep 03Second quarter 2023 earnings releasedSecond quarter 2023 results: EPS: Rp12.47. Net income: Rp11.9b (up Rp11.9b from 2Q 2022).
Reported Earnings • May 08Full year 2022 earnings released: EPS: Rp12.15 (vs Rp8.27 in FY 2021)Full year 2022 results: EPS: Rp12.15 (up from Rp8.27 in FY 2021). Revenue: Rp103.3b (up 55% from FY 2021). Net income: Rp7.99b (up 76% from FY 2021). Profit margin: 7.7% (up from 6.8% in FY 2021). The increase in margin was driven by higher revenue.
New Risk • May 18New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: Rp172.5b (US$9.83m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company.
공시 • May 04PT OBM Drilchem Tbk, Annual General Meeting, Jun 10, 2026PT OBM Drilchem Tbk, Annual General Meeting, Jun 10, 2026. Location: jakarta Indonesia
New Risk • Mar 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Market cap is less than US$100m (Rp188.6b market cap, or US$11.1m).
Valuation Update With 7 Day Price Move • Jan 07Investor sentiment improves as stock rises 25%After last week's 25% share price gain to Rp340, the stock trades at a trailing P/E ratio of 8.3x. Average trailing P/E is 18x in the Chemicals industry in Indonesia. Total returns to shareholders of 105% over the past three years.
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment improves as stock rises 19%After last week's 19% share price gain to Rp296, the stock trades at a trailing P/E ratio of 7.2x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 50% over the past three years.
Board Change • Oct 14No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 4 highly experienced directors. No independent directors (4 non-independent directors). Commissioner Andang Bachtiar was the last director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Jun 19PT OBM Drilchem Tbk, Annual General Meeting, Jun 19, 2025PT OBM Drilchem Tbk, Annual General Meeting, Jun 19, 2025. Location: conference room suite 7e 7th fl dipo business, center jl gatot subroto kav 50-52 rt 001 rw 007, kel tanah abang jakarta pusat dk jakarta kota adm, jakarta pusat dki, Indonesia
Valuation Update With 7 Day Price Move • Nov 07Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to Rp187, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 12x in the Chemicals industry in Indonesia. Total loss to shareholders of 27% over the past year.
Recent Insider Transactions • Aug 29President Director recently sold Rp1.2b worth of stockOn the 23rd of August, Ryanto Husodo sold around 5m shares on-market at roughly Rp255 per share. This transaction amounted to 6.9% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Ryanto's only on-market trade for the last 12 months.
New Risk • Jun 16New major risk - Earnings qualityThe company has a high level of non-cash earnings. Accrual ratio: 21% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (21% accrual ratio). Minor Risk Market cap is less than US$100m (Rp212.8b market cap, or US$13.0m).
Reported Earnings • Jun 04First quarter 2024 earnings released: EPS: Rp23.63 (vs Rp11.75 in 1Q 2023)First quarter 2024 results: EPS: Rp23.63 (up from Rp11.75 in 1Q 2023). Revenue: Rp53.4b (up 46% from 1Q 2023). Net income: Rp19.0b (up 101% from 1Q 2023). Profit margin: 36% (up from 26% in 1Q 2023). The increase in margin was driven by higher revenue.
공시 • May 09PT OBM Drilchem Tbk, Annual General Meeting, Jun 13, 2024PT OBM Drilchem Tbk, Annual General Meeting, Jun 13, 2024.
Reported Earnings • Apr 02Full year 2023 earnings released: EPS: Rp30.26 (vs Rp12.15 in FY 2022)Full year 2023 results: EPS: Rp30.26 (up from Rp12.15 in FY 2022). Revenue: Rp154.5b (up 50% from FY 2022). Net income: Rp24.4b (up 205% from FY 2022). Profit margin: 16% (up from 7.7% in FY 2022). The increase in margin was driven by higher revenue.
Reported Earnings • Dec 03Third quarter 2023 earnings releasedThird quarter 2023 results: EPS: Rp21.13. Net income: Rp17.0b (up Rp17.0b from 3Q 2022).
Reported Earnings • Sep 03Second quarter 2023 earnings releasedSecond quarter 2023 results: EPS: Rp12.47. Net income: Rp11.9b (up Rp11.9b from 2Q 2022).
Valuation Update With 7 Day Price Move • Aug 08Investor sentiment improves as stock rises 22%After last week's 22% share price gain to Rp276, the stock trades at a trailing P/E ratio of 27.8x. Average trailing P/E is 18x in the Chemicals industry in Indonesia. Total returns to shareholders of 96% over the past year.
New Risk • Jul 07New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indonesian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding). Market cap is less than US$100m (Rp178.9b market cap, or US$11.8m).
Valuation Update With 7 Day Price Move • Jul 07Investor sentiment improves as stock rises 23%After last week's 23% share price gain to Rp222, the stock trades at a trailing P/E ratio of 22.4x. Average trailing P/E is 16x in the Chemicals industry in Indonesia. Total returns to shareholders of 56% over the past year.
New Risk • Jun 12New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (Rp145.1b market cap, or US$9.75m). Minor Risk Shareholders have been diluted in the past year (10% increase in shares outstanding).
Reported Earnings • May 08Full year 2022 earnings released: EPS: Rp12.15 (vs Rp8.27 in FY 2021)Full year 2022 results: EPS: Rp12.15 (up from Rp8.27 in FY 2021). Revenue: Rp103.3b (up 55% from FY 2021). Net income: Rp7.99b (up 76% from FY 2021). Profit margin: 7.7% (up from 6.8% in FY 2021). The increase in margin was driven by higher revenue.
Valuation Update With 7 Day Price Move • May 03Investor sentiment improves as stock rises 24%After last week's 24% share price gain to Rp188, the stock trades at a trailing P/E ratio of 30.2x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 100% over the past year.
Valuation Update With 7 Day Price Move • Feb 27Investor sentiment improves as stock rises 26%After last week's 26% share price gain to Rp216, the stock trades at a trailing P/E ratio of 34.8x. Average trailing P/E is 13x in the Chemicals industry in Indonesia. Total returns to shareholders of 88% over the past year.
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Tumbur Nainggolan was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Independent Commissioner Tumbur Nainggolan was the last independent director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.